What Is Hemoptysis?
May 14, 2022
Source: Cainiu Health
Dr. Li Man
Introduction
Hemoptysis is not a disease itself but rather a symptom—a common clinical manifestation. There are numerous causes of hemoptysis, with the most frequent being respiratory disorders, such as bronchiectasis, lung cancer, pulmonary tuberculosis, lung abscess, pulmonary embolism, pulmonary parasitic infections, and pulmonary fungal infections. Cardiovascular diseases may also cause hemoptysis; a relatively common example is hemoptysis secondary to mitral stenosis.
Hemoptysis can occur in numerous diseases, yet each disease presents with its own distinct accompanying symptoms and physical signs. Common associated symptoms include fever, chest pain, paroxysmal coughing, purulent sputum, weight loss, mucocutaneous bleeding, jaundice, cyanosis, and enlargement of superficial lymph nodes in the neck and other regions. So, what is “hemoptysis disease”?
What Is Hemoptysis?
Hemoptysis is not a disease itself but rather a clinical symptom—commonly encountered in medical practice. Its underlying causes are diverse and frequently associated with the following conditions: Respiratory disorders—including bronchiectasis, lung cancer, pulmonary tuberculosis, lung abscess, pulmonary embolism, pulmonary parasitic infections, and pulmonary fungal infections. Cardiovascular diseases—most commonly mitral stenosis leading to hemoptysis; less frequently, pulmonary hypertension secondary to congenital heart disease, primary pulmonary hypertension, or vasculitis.
Hematologic disorders—such as leukemia, immune thrombocytopenic purpura (ITP), hemophilia, and aplastic anemia. Connective tissue diseases—including systemic lupus erythematosus (SLE), granulomatosis with polyangiitis (formerly Wegener’s granulomatosis), and Behçet’s disease. Certain infectious diseases may also cause hemoptysis—for example, epidemic hemorrhagic fever and pulmonary leptospirosis. Primary treatment approaches for hemoptysis include pharmacologic hemostasis. Commonly used agents include Yunnan Baiyao (a traditional Chinese hemostatic agent), tranexamic acid, etamsylate, and vitamin K1. If pharmacologic therapy fails to control bleeding, surgical interventions—including lung transplantation—may be considered.
We hope this response has been helpful to you!
